We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Cinemark, Diamondback Energy and Omnicell
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 11, 2026 – Stocks in this week’s article are Cinemark Holdings, Inc. (CNK - Free Report) , Diamondback Energy, Inc. (FANG - Free Report) and Omnicell, Inc. (OMCL - Free Report) .
Buy These 3 Stocks with Broker Rating Upgrades for Big Gains
U.S. equity markets have posted modest gains thus far in 2026, despite rising concerns about Big Tech’s substantial artificial intelligence (AI) investments and scrutiny of AI infrastructure spending following the midterm elections. Elevated Treasury yields, volatile oil prices, persistent inflation and tariff-related uncertainty have weighed on investor sentiment. The Federal Reserve’s hawkish monetary policy stance has fueled concerns about higher borrowing costs. Nevertheless, resilient corporate earnings and declining oil prices have strengthened investor confidence, helping sustain the broader market’s recovery.
In this scenario, choosing the right stock can become difficult. One way to simplify this task is to follow brokers’ recommendations. Stocks like Cinemark Holdings, Inc., Diamondback Energy, Inc. and Omnicell, Inc. are worth adding to your portfolio.
Broker recommendations typically stem from extensive research involving management discussions, regulatory disclosures, earnings transcripts, channel checks and industry evaluations. This rigorous process helps analysts assess company fundamentals in the context of macroeconomic conditions, sector trends, competitive positioning and performance relative to peers.
An upgrade in broker ratings generally signals increased optimism about a company’s outlook, highlighting favorable developments that consensus estimates or prevailing share prices may not fully capture. These revisions can reflect stronger earnings potential, compelling valuations or improving market sentiment.
However, investors should avoid relying solely on broker upgrades. Evaluating these signals alongside fundamentals, earnings trends and valuation measures can support informed investment decisions as part of a balanced and disciplined investment approach. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Stocks with Upgraded Broker Ratings to Bet on
Plano, TX-based Cinemark Holdings operates in the theatrical exhibition industry. CNK has a network of movie theatres across the United States and Latin America.
CNK’s 2026 earnings are expected to soar 164.4% year over year. Cinemark Holdings, which currently sports a Zacks Rank #1, has witnessed a 7.1% upward revision in broker ratings over the past four weeks.
Diamondback Energy, based in Midland, TX, is an independent oil and gas exploration and production company with its primary focus on the Permian Basin. FANG’s activities are concentrated in the Wolfcamp, Spraberry and Bone Spring formations.
Diamondback Energy’s 2026 earnings are projected to jump 68.8% year over year. FANG, which sports a Zacks Rank #1 at present, has seen a 3% increase in broker ratings over the past four weeks.
Headquartered in Fort Worth, TX, Omnicell develops and markets medication management solutions and adherence tools for healthcare systems and pharmacies. OMCL operated through two reporting segments: Automation and Analytics and Medication Adherence.
OMCL’s 2026 earnings are expected to surge 47.5% year over year. Omnicell, which currently sports a Zacks Rank #1, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights include Cinemark, Diamondback Energy and Omnicell
For Immediate Release
Chicago, IL – November 11, 2026 – Stocks in this week’s article are Cinemark Holdings, Inc. (CNK - Free Report) , Diamondback Energy, Inc. (FANG - Free Report) and Omnicell, Inc. (OMCL - Free Report) .
Buy These 3 Stocks with Broker Rating Upgrades for Big Gains
U.S. equity markets have posted modest gains thus far in 2026, despite rising concerns about Big Tech’s substantial artificial intelligence (AI) investments and scrutiny of AI infrastructure spending following the midterm elections. Elevated Treasury yields, volatile oil prices, persistent inflation and tariff-related uncertainty have weighed on investor sentiment. The Federal Reserve’s hawkish monetary policy stance has fueled concerns about higher borrowing costs. Nevertheless, resilient corporate earnings and declining oil prices have strengthened investor confidence, helping sustain the broader market’s recovery.
In this scenario, choosing the right stock can become difficult. One way to simplify this task is to follow brokers’ recommendations. Stocks like Cinemark Holdings, Inc., Diamondback Energy, Inc. and Omnicell, Inc. are worth adding to your portfolio.
Broker recommendations typically stem from extensive research involving management discussions, regulatory disclosures, earnings transcripts, channel checks and industry evaluations. This rigorous process helps analysts assess company fundamentals in the context of macroeconomic conditions, sector trends, competitive positioning and performance relative to peers.
An upgrade in broker ratings generally signals increased optimism about a company’s outlook, highlighting favorable developments that consensus estimates or prevailing share prices may not fully capture. These revisions can reflect stronger earnings potential, compelling valuations or improving market sentiment.
However, investors should avoid relying solely on broker upgrades. Evaluating these signals alongside fundamentals, earnings trends and valuation measures can support informed investment decisions as part of a balanced and disciplined investment approach. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Stocks with Upgraded Broker Ratings to Bet on
Plano, TX-based Cinemark Holdings operates in the theatrical exhibition industry. CNK has a network of movie theatres across the United States and Latin America.
CNK’s 2026 earnings are expected to soar 164.4% year over year. Cinemark Holdings, which currently sports a Zacks Rank #1, has witnessed a 7.1% upward revision in broker ratings over the past four weeks.
Diamondback Energy, based in Midland, TX, is an independent oil and gas exploration and production company with its primary focus on the Permian Basin. FANG’s activities are concentrated in the Wolfcamp, Spraberry and Bone Spring formations.
Diamondback Energy’s 2026 earnings are projected to jump 68.8% year over year. FANG, which sports a Zacks Rank #1 at present, has seen a 3% increase in broker ratings over the past four weeks.
Headquartered in Fort Worth, TX, Omnicell develops and markets medication management solutions and adherence tools for healthcare systems and pharmacies. OMCL operated through two reporting segments: Automation and Analytics and Medication Adherence.
OMCL’s 2026 earnings are expected to surge 47.5% year over year. Omnicell, which currently sports a Zacks Rank #1, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.
Free: Instant Access to Zacks' Market-Crushing Strategies
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can tap into those powerful strategies – and the high-potential stocks they uncover – free. No strings attached.
Get all the details here >>
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/3027378/buy-these-3-stocks-with-broker-rating-upgrades-for-big-gains